| Autor: |
Chlorogiannis DD; Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA., Pargaonkar S; Division of Hospital Medicine, Jacobi Medical Center, NYC H+H, Albert Einstein College of Medicine, New York, NY 10461, USA., Apostolos A; 1st Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Hippokrateion General Hospital of Athens, 11527 Athens, Greece., Vythoulkas-Biotis N; 3rd Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens, Thoracic Diseases Hospital of Athens 'Sotiria', 11527 Athens, Greece., Kokkinidis DG; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT 06510, USA., Nagraj S; Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA. |
| Abstrakt: |
As the prevalence of cardiovascular disease continues to increase, early identification of patients at high risk of major adverse cardiovascular events (MACE) using reliable diagnostic modalities is important. Transcatheter aortic valve implantation (TAVI) is a minimally invasive percutaneous procedure used to replace the aortic valve with a bioprosthetic one, often without the need for surgery. Extra coronary calcification in the ascending and/or descending thoracic aorta, aortic arch, and abdominal aorta has recently been identified as a method to quantify the extent of atherosclerotic cardiovascular disease. However, its definitive role in the prediction of MACE remains unclear. We performed a comprehensive review to summarize the current literature on the diagnostic and predictive value of thoracic and abdominal aortic calcification, as quantified in computed tomography, for the association, risk stratification, and prediction of MACE and after TAVI procedures. Despite increasing evidence, the predictive role of thoracic calcification still remains unproven, with a need for carefully tailored studies to confirm these findings. |
